Deals
Anthem-Cigna Deal Tied to Rival Mergers in Antitrust Review
Anthem-Cigna Merger to Come Under Regulator Scrutiny
This article is for subscribers only.
The fate of Anthem Inc.’s proposed takeover of Cigna Corp. is now linked with that of Aetna Inc.’s bid for Humana Inc. as antitrust officials vow to scrutinize the industry as a whole amid the frenzy of dealmaking.
The $48.4 billion purchase of Cigna announced Friday would cut the number of major health insurers to three from five, making it challenging for Anthem and its rivals to win approval from the Justice Department, antitrust experts say.